Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegaly

PURPOSE: Recent data indicate that extended dosing intervals (EDIs) with lanreotide autogel 120 mg are effective and well-received among patients with acromegaly who have achieved biochemical control with monthly injections of long-acting somatostatin analogues (SSAs). We further evaluated the effec...

詳細記述

保存先:
書誌詳細
出版年:Endocrine
主要な著者: Bernabéu, Ignacio, Fajardo, Carmen, Marazuela, Mónica, Cordido, Fernando, Venegas, Eva María, de Pablos-Velasco, Pedro, Maroto, Gonzalo Piedrola, Olvera, María Pilar, de Paz, Isabel Pavón, Carvalho, Davide, Romero, Carme, De la Cruz, Guillermo, Escolá, Cristina Álvarez
フォーマット: Artigo
言語:Inglês
出版事項: Springer US 2020
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7674328/
https://ncbi.nlm.nih.gov/pubmed/32725444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12020-020-02424-z
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料